Literature DB >> 30605914

A Pharmacogenomics Clinical Decision Support Service Based on FHIR and CDS Hooks.

R H Dolin1, A Boxwala1, J Shalaby1.   

Abstract

OBJECTIVES: Pharmacogenomics (PGx) is often considered a low-hanging fruit for genomics-electronic health record (EHR) integrations, and many have expressed the notion that drug-gene interaction checking might one day become as much a commodity in EHRs as drug-drug and drug-allergy checking. In addition, the U.S. Office of the National Coordinator has recognized the trend toward storing complete sequencing data outside the EHR in a Genomic Archiving and Communication System (GACS) and has emphasized the need for "pilots that test Fast Healthcare Interoperability Resources (FHIR) Genomics for GACS integration with EHRs." We sought to develop a PGx clinical decision support (CDS) service, leveraging the emerging FHIR and CDS Hooks standards, and based on an assumption that pharmacogene sequencing data would be stored alongside the EHR in a GACS.
METHODS: We developed a PGx CDS service as a functional prototype. The service is triggered by a medication order in the EHR. When evoked, the service looks for relevant genetic data in a GACS and returns corresponding recommendations back to the ordering clinician. Where the patient has no genetic data on file, the service can recommend pretreatment genetic testing where applicable.
RESULTS: Overall, we were able to meet our objectives and deploy a functional prototype, interfaced with a commercial EHR. We identified several areas where FHIR or CDS Hooks lacked necessary semantics or have implementation ambiguity. Primary FHIR challenges included multiple ways to say the same thing, which exacerbated the complexity of variant to allele conversion and lack of representation of deoxyribonucleic acid region(s) studied. Primary CDS Hooks challenges included the complexity of executing an authenticated query against one system (GACS) upon being triggered by a different system (the EHR), and limitations in the types of actionable recommendations that can be returned to the EHR.
CONCLUSIONS: In conclusion, we have found that PGx CDS based on FHIR and CDS Hooks appears to represent a promising means of genomics-EHR integration. More real-world testing along with a set of use-case driven GACS interface requirements will push us closer to the U.S. National Human Genome Research Institute vision of a plug-in PGx app. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30605914     DOI: 10.1055/s-0038-1676466

Source DB:  PubMed          Journal:  Methods Inf Med        ISSN: 0026-1270            Impact factor:   2.176


  17 in total

1.  FHIR Lab Reports: using SMART on FHIR and CDS Hooks to increase the clinical utility of pharmacogenomic laboratory test results.

Authors:  Michael Watkins; Karen Eilbeck
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2020-05-30

Review 2.  Personalized Medicine and the Power of Electronic Health Records.

Authors:  Noura S Abul-Husn; Eimear E Kenny
Journal:  Cell       Date:  2019-03-21       Impact factor: 41.582

3.  GARDE: a standards-based clinical decision support platform for identifying population health management cohorts.

Authors:  Richard L Bradshaw; Kensaku Kawamoto; Kimberly A Kaphingst; Wendy K Kohlmann; Rachel Hess; Michael C Flynn; Claude J Nanjo; Phillip B Warner; Jianlin Shi; Keaton Morgan; Kadyn Kimball; Pallavi Ranade-Kharkar; Ophira Ginsburg; Melody Goodman; Rachelle Chambers; Devin Mann; Scott P Narus; Javier Gonzalez; Shane Loomis; Priscilla Chan; Rachel Monahan; Emerson P Borsato; David E Shields; Douglas K Martin; Cecilia M Kessler; Guilherme Del Fiol
Journal:  J Am Med Inform Assoc       Date:  2022-04-13       Impact factor: 4.497

Review 4.  Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities.

Authors:  Kathleen F Mittendorf; Sarah Knerr; Tia L Kauffman; Nangel M Lindberg; Katherine P Anderson; Heather Spencer Feigelson; Marian J Gilmore; Jessica Ezzell Hunter; Galen Joseph; Stephanie A Kraft; Jamilyn M Zepp; Sapna Syngal; Benjamin S Wilfond; Katrina A B Goddard
Journal:  JCO Precis Oncol       Date:  2021-11-03

5.  Creation of a pharmacogenomics patient portal complementary to an existing institutional provider-facing clinical decision support system.

Authors:  Elizabeth Lipschultz; Keith Danahey; Tien M Truong; Emily Schierer; Samuel L Volchenboum; Mark J Ratain; Peter H O'Donnell
Journal:  JAMIA Open       Date:  2021-08-27

6.  Using CDS Hooks to increase SMART on FHIR app utilization: a cluster-randomized trial.

Authors:  Keaton L Morgan; Polina V Kukhareva; Phillip B Warner; Jonah Wilkof; Meir Snyder; Devin Horton; Troy Madsen; Joseph Habboushe; Kensaku Kawamoto
Journal:  J Am Med Inform Assoc       Date:  2022-08-16       Impact factor: 7.942

7.  Barriers to using clinical decision support in ambulatory care: Do clinics in health systems fare better?

Authors:  Yunfeng Shi; Alejandro Amill-Rosario; Robert S Rudin; Shira H Fischer; Paul Shekelle; Dennis P Scanlon; Cheryl L Damberg
Journal:  J Am Med Inform Assoc       Date:  2021-07-30       Impact factor: 4.497

8.  Infobuttons for Genomic Medicine: Requirements and Barriers.

Authors:  Luke V Rasmussen; John J Connolly; Guilherme Del Fiol; Robert R Freimuth; Douglas B Pet; Josh F Peterson; Brian H Shirts; Justin B Starren; Marc S Williams; Nephi Walton; Casey Overby Taylor
Journal:  Appl Clin Inform       Date:  2021-05-12       Impact factor: 2.342

Review 9.  Engaging pharmacogenomics in pain management and opioid selection.

Authors:  David R Bright; Natasha Petry; Eric Roath; Tyler Gibb
Journal:  Pharmacogenomics       Date:  2021-09-15       Impact factor: 2.638

10.  Genomic considerations for FHIR®; eMERGE implementation lessons.

Authors:  Mullai Murugan; Lawrence J Babb; Casey Overby Taylor; Luke V Rasmussen; Robert R Freimuth; Eric Venner; Fei Yan; Victoria Yi; Stephen J Granite; Hana Zouk; Samuel J Aronson; Kevin Power; Alex Fedotov; David R Crosslin; David Fasel; Gail P Jarvik; Hakon Hakonarson; Hana Bangash; Iftikhar J Kullo; John J Connolly; Jordan G Nestor; Pedro J Caraballo; WeiQi Wei; Ken Wiley; Heidi L Rehm; Richard A Gibbs
Journal:  J Biomed Inform       Date:  2021-04-28       Impact factor: 8.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.